HK2 and colorectal carcinoma: HKII overexpression is correlated with poor prognosis in CRC and has been proposed as a therapeutic target due to its importance in glycolysis and cellular survival (Hamabe et al., 2014; Ho and Coomber, 2016; Krasnov et al., 2016).